‘This prospective cohort study enrolled students from two schools aged 13–18 years who received the second dose of the BNT162b2 mRNA COVID-19 vaccine.
Cardiovascular effects were found in 29.24% of patients, ranging from tachycardia, palpitation, and myopericarditis.’
https://www.preprints.org/manuscript/202208.0151/v1
